The PPMD team is joined by leading Duchenne researchers to discuss exciting areas of research in development that hold promise for Duchenne, such as gene editing and non-viral delivery. Panelists: Kevin Flanigan, MD, Nationwide Children’s Hospital Melissa Spencer, PhD, UCLA 6 years ago 2020 PPMD Virtual Conference: Live Sessions,Conferences & Meetings You may also like 49:36 DPT Meeting: Panel 1 – Protocol Objectives & Eligibility 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:07:15 DPT Meeting: Panel 2 – Endpoints & Schedule of Events 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 44:50 DPT Meeting: Panel 3 – Operations & Governance 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:02:36 DPT Meeting: Parent Commentary & Advocacy Perspective 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 18:59 DPT Meeting: Key Takeaways & Next Steps 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:22:00 Understanding Duchenne From The Start 7 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:09:37 Understanding Duchenne Behavioral Challenges (PPMD 2019 Conference) 7 years ago 2019 PPMD Annual Conference,Conferences & Meetings 19:21 Where Have We Come From & Where are We Going? (PPMD 2019 Conference) 7 years ago 2019 PPMD Annual Conference,Conferences & Meetings «1…2526272829»Page 27 of 29